In the last trading session, 1.11 million TNF Pharmaceuticals Inc (NASDAQ:TNFA) shares changed hands as the company’s beta touched 2.13. With the company’s per share price at $1.48 changed hands at $0.03 or 2.07% during last session, the market valuation stood at $4.07M. TNFA’s last price was a discount, traded about -325.68% off its 52-week high of $6.30. The share price had its 52-week low at $1.05, which suggests the last value was 29.05% up since then. When we look at TNF Pharmaceuticals Inc’s average trading volume, we note the 10-day average is 0.12 million shares, with the 3-month average coming to 118.51K.

TNF Pharmaceuticals Inc (NASDAQ:TNFA) trade information

Instantly TNFA was in green as seen at the end of in last trading. With action 26.50%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 28.70%, with the 5-day performance at 26.50% in the green. However, in the 30-day time frame, TNF Pharmaceuticals Inc (NASDAQ:TNFA) is 21.31% up. Looking at the short shares, we see there were 0.27 million shares sold at short interest cover period of 6.39 days.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 67.29%.

TNFA Dividends

TNF Pharmaceuticals Inc is expected to release its next quarterly earnings report in February.

Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund . With 13.69 shares estimated at $20259.0 under it, the former controlled 0.50% of total outstanding shares. On the other hand, Fidelity Extended Market Index Fund held about 0.41% of the shares, roughly 11.43 shares worth around $16910.0.